Literature DB >> 7225271

Control of postoperative pain by interactive demand analgesia.

C J Hull, A Sibbald.   

Abstract

A demand analgesia apparatus is described. It communicates with the patient by means of spoken messages in any desired language, so that preliminary instruction is unnecessary. Dosage is limited by a reduction in respiratory rate, and by a series of electronic fail-safe circuits. Operation of the system is illustrated in a series of 10 patients given fentanyl "on demand" for the first 12 h after operation. The mean dose rate 0.73 +/- 0.49 microgram min-1. There was no evidence of cumulation or tolerance during the period of study.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7225271     DOI: 10.1093/bja/53.4.385

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

Review 1.  [Pain and anesthesiology : aspects of the development of modern pain therapy in the twentieth century].

Authors:  W Witte
Journal:  Anaesthesist       Date:  2011-06       Impact factor: 1.041

2.  Irrational attitudes toward addicts and narcotics.

Authors:  S W Perry
Journal:  Bull N Y Acad Med       Date:  1985-10

Review 3.  Current guidelines for the treatment of acute pain in children.

Authors:  V Bhatt-Mehta
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

Review 4.  Newer methods of delivery of opiates for relief of pain.

Authors:  P J Slattery; R A Boas
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

Review 5.  Patient-controlled analgesia. Pharmacokinetic and therapeutic considerations.

Authors:  H F Hill; L E Mather
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of fentanyl and its newer derivatives.

Authors:  L E Mather
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

Review 7.  Pain--mechanics and management.

Authors:  H L Fields; J D Levine
Journal:  West J Med       Date:  1984-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.